STOCK TITAN

Silk Road Medical Inc - SILK STOCK NEWS

Welcome to our dedicated news page for Silk Road Medical (Ticker: SILK), a resource for investors and traders seeking the latest updates and insights on Silk Road Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Silk Road Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Silk Road Medical's position in the market.

Rhea-AI Summary
Silk Road Medical, Inc. will report financial results for Q3 2023 on November 8th, 2023. A corresponding audio webcast will be available for participants to listen to the conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.59%
Tags
conferences earnings
-
Rhea-AI Summary
Silk Road Medical announces preliminary Q3 2023 revenue of $44.4 million, a 19% increase YoY, and updates full year 2023 revenue guidance to range from $170 million to $174 million, representing 23% to 26% growth over the prior year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-49.04%
Tags
-
Rhea-AI Summary
Silk Road Medical CEO Erica Rogers plans to retire, company working with executive search firm to find successor
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-49.04%
Tags
none
Rhea-AI Summary
Silk Road Medical to present at CL King 21st Annual Best Ideas Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.54%
Tags
conferences
-
Rhea-AI Summary
SILK - Silk Road Medical, Inc. to Present at UBS MedTech, Tools and Genomics Summit on August 17, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.67%
Tags
Rhea-AI Summary
Silk Road Medical, Inc. (Nasdaq: SILK) will report financial results for the second quarter 2023 on August 1st, 2023. The company focuses on reducing the risk of stroke and its impact. A conference call will be held at 1:30 p.m. PT / 4:30 p.m. ET and can be accessed via online registration. The webcast will be available for replay on the company's investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-28.58%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.89%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.03%
Tags
none
Rhea-AI Summary
Silk Road Medical, Inc. will host an investor education webcast on May 25, 2023, to educate investors on TCAR and the treatment of carotid artery disease. The event will include a discussion between Dr. Sumaira Macdonald and key opinion leaders in the field.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.03%
Tags
none
Silk Road Medical Inc

Nasdaq:SILK

SILK Rankings

SILK Stock Data

712.98M
38.29M
5.94%
105.6%
10.44%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Sunnyvale

About SILK

silk road medical, inc. is a privately held company located in sunnyvale, california, dedicated to preventing the devastating burden of stroke through surgical innovation. the company develops and manufactures less-invasive medical devices to improve the treatment of vascular disease through proprietary transcarotid therapies. by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with carotid artery disease. our history is one of deep collaboration with vascular specialists and our future will be guided by continuous learning, observation and improvement. for more information on the company, visit our website at http://silkroadmed.com/. the transcarotid artery revascularization (tcar) procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. th